Author Topic: New company specializing in stem cell platform for MS and other ills raises $48.5M  (Read 60 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8218
  • MS diagnosed 1980
  • Location: Pacific Northwest
There have been many warnings against going for stem-cell treatments that aren't quite the real thing. It's hard to know how real this latest development is, but the Magenta organization seems to have collected a substantial sum--and is claiming to have some vague connection with Stanford University, Massachusetts General Hospital, and Harvard University. The article is in Multiple Sclerosis News Today, November 19:

https://multiplesclerosisnewstoday.com/2016/11/21/magenta-therapeutics-raises-48.5-million-in-financing-to-begin-stem-cell-platform?utm_source=Multiple+Sclerosis&utm_campaign=c7b308e65b-RSS_MONDAY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-c7b308e65b-71286581
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
40 Views
Last post June 11, 2016, 02:36:36 pm
by agate
0 Replies
27 Views
Last post April 30, 2017, 03:52:34 pm
by agate
0 Replies
30 Views
Last post October 05, 2017, 05:59:46 am
by agate
0 Replies
40 Views
Last post October 20, 2017, 04:29:32 pm
by agate
0 Replies
31 Views
Last post July 26, 2018, 03:42:33 pm
by agate